Heparin-binding protein in sputum as a marker of pulmonary inflammation, lung function, and bacterial load in children with cystic fibrosis
BMC Pulmonary Medicine Jun 26, 2018
Hovold G, et al. - In this study involving cystic fibrosis (CF) patients, aged 6–18 years, researchers assessed the neutrophil-derived protein Heparin-binding protein (HBP) as a potential sputum marker of airway inflammation and bacterial load. They carried out a prospective 6 months follow- up in these subjects, with sputum sampling at every visit to the CF clinic. Using sputum samples, they analyzed sputum-HBP, neutrophil elastase activity and total bacterial load with ELISA, chromogenic assay, and RT-PCR (Real-Time Polymerase Chain Reaction) of the 16 s rDNA gene, respectively. Comparisons of data to lung function parameters and airway symptoms was performed. They found a correlation of HBP and elastase with a decrease in FEV1%predicted (Forced expiratory volume in one second, % of predicted) vs the patients´ individual baseline pulmonary function (&DeltaFEV1), but not with bacterial load. Overall, sputum HBP showed utility as a promising marker of airway inflammation and pulmonary function in children with CF.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries